HF Advisory Group LLC lowered its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 48.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,446 shares of the company’s stock after selling 4,151 shares during the period. HF Advisory Group LLC’s holdings in Cardinal Health were worth $526,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. HB Wealth Management LLC grew its position in shares of Cardinal Health by 12.5% during the 4th quarter. HB Wealth Management LLC now owns 6,296 shares of the company’s stock valued at $745,000 after acquiring an additional 698 shares during the period. Arkadios Wealth Advisors purchased a new position in Cardinal Health in the fourth quarter valued at approximately $242,000. Merit Financial Group LLC bought a new position in Cardinal Health during the fourth quarter valued at $433,000. Avanza Fonder AB purchased a new stake in Cardinal Health in the fourth quarter worth $2,999,000. Finally, KMG Fiduciary Partners LLC raised its stake in shares of Cardinal Health by 2.8% in the fourth quarter. KMG Fiduciary Partners LLC now owns 79,977 shares of the company’s stock valued at $9,459,000 after buying an additional 2,141 shares during the period. Institutional investors own 87.17% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on CAH shares. Mizuho initiated coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective for the company. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Barclays upped their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Finally, UBS Group increased their target price on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $133.29.
Cardinal Health Price Performance
Shares of NYSE:CAH opened at $126.27 on Friday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $127.27. The firm has a market capitalization of $30.56 billion, a price-to-earnings ratio of 24.57, a PEG ratio of 1.48 and a beta of 0.63. The company’s fifty day moving average price is $120.75 and its 200-day moving average price is $111.92.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.73 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.82 EPS for the current year.
Cardinal Health Cuts Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health’s payout ratio is 39.30%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
- Five stocks we like better than Cardinal Health
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- The How And Why of Investing in Oil Stocks
- Oilfield Leader SLB: An AI Name You Need to Know
- What Are the U.K. Market Holidays? How to Invest and Trade
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.